Since joining BD, Mr. Forlenza has held various positions of increasing responsibility in the United States and Europe. Of note, he served four years as President of BD Diagnostic Systems, a worldwide business focused on developing and marketing infectious disease diagnostic platforms. During this assignment Mr. Forlenza was instrumental in the early development of two significant new infectious disease diagnostics systems, BD ProbeTec™ ET and BD Phoenix™. In addition to his new responsibilities with BD Biosciences, Mr. Forlenza will continue to lead BD Technologies. Mr. Forlenza holds a BS in Chemical Engineering from Lehigh University and a MBA from the Wharton Graduate School, University of Pennsylvania.